Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Feb 15;205(4):375-377.
doi: 10.1164/rccm.202110-2322ED.

Mechanisms of Mast Cell Activation in Severe Asthma: Beyond IgE

Affiliations
Editorial

Mechanisms of Mast Cell Activation in Severe Asthma: Beyond IgE

Peter Bradding. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Examples of ligands and receptors capable of activating human mast cells. Many of these ligands and activating stimuli are active in the airways of people with asthma and therefore likely to contribute to the ongoing mast cell activation evident in asthmatic airways. The downstream signaling pathways for many of these receptors in mast cells and how they interact with each other are not fully understood. Among the well-known signaling pathways are the PLC-γ and PI3K pathways, which mobilize intracellular Ca2+, leading to Ca2+ influx via Orai channels. Modified from Reference . ADDS = antibody-dependent degranulatory synapse; CADM1 = cell adhesion molecule-1; CRH = corticotropin-releasing hormone; CRH-R = CRH receptor; FcR = Fc receptor; IP3 = inositol-1,4,5-triphosphate; LT = leukotriene; MBP = major basic protein; MRGPRX2 = Mas-related G protein–coupled receptor-X2; PAF = platelet-activating factor; PI3K = phosphoinositide 3-kinase; PAR = protease-activated receptor; PGN = peptidoglycan; PLC-γ = phospholipase Cγ; PM10 = particulate matter ⩽10 μm in aerodynamic diameter; R = receptor; SCF = stem cell factor; TLR = Toll-like receptor; TNF = tumor necrosis factor; TSLP = thymic stromal lymphopoietin.

Comment on

References

    1. Bradding P, Arthur G. Mast cells in asthma--state of the art. Clin Exp Allergy . 2016;46:194–263. - PubMed
    1. Trivedi NH, Guentzel MN, Rodriguez AR, Yu JJ, Forsthuber TG, Arulanandam BP. Mast cells: multitalented facilitators of protection against bacterial pathogens. Expert Rev Clin Immunol . 2013;9:129–138. - PMC - PubMed
    1. Madjene LC, Pons M, Danelli L, Claver J, Ali L, Madera-Salcedo IK, et al. Mast cells in renal inflammation and fibrosis: lessons learnt from animal studies. Mol Immunol . 2015;63:86–93. - PubMed
    1. Akahoshi M, Song CH, Piliponsky AM, Metz M, Guzzetta A, Abrink M, et al. Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice. J Clin Invest . 2011;121:4180–4191. - PMC - PubMed
    1. Welsh TJ, Green RH, Richardson D, Waller DA, O’Byrne KJ, Bradding P. Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol . 2005;23:8959–8967. - PubMed

Substances